Cargando…
Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol
BACKGROUND: Preeclampsia is defined as new onset of hypertension and proteinuria at gestational week 20 or after. However, use of these measures to predict preeclampsia before its clinical onset is unreliable, and evidence suggests that preeclampsia, eclampsia, or hemolysis, elevated liver enzymes a...
Autores principales: | Hund, Martin, Allegranza, Deirdre, Schoedl, Maria, Dilba, Peter, Verhagen-Kamerbeek, Wilma, Stepan, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262142/ https://www.ncbi.nlm.nih.gov/pubmed/25230734 http://dx.doi.org/10.1186/1471-2393-14-324 |
Ejemplares similares
-
Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia
por: Klein, Evelyn, et al.
Publicado: (2016) -
Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia
por: Bian, Xuming, et al.
Publicado: (2019) -
Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome
por: Stepan, Holger, et al.
Publicado: (2020) -
Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study
por: Ohkuchi, Akihide, et al.
Publicado: (2021) -
Soluble fms‐like tyrosine kinase‐1 to placental growth factor ratio: ruling out pre‐eclampsia for up to 4 weeks and value of retesting
por: Zeisler, H., et al.
Publicado: (2019)